Biotron Limited Profit Margin

Biotron Limited (BITRF) currently reports a profit margin of -78.46% as of June 2026. That compares with -225.24% in the prior-year period — up 65.2% year over year. That is below the Healthcare sector average of 9.71%. Use the charts on this page to explore Biotron Limited's profit margin history and peer comparisons.

Biotron Limited's profit margin increased from -225.24% to -78.46% — a 65.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biotron Limited's profit margin of -78.46% is lower than the Healthcare sector average of 9.71%. That is roughly 908.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Biotron Limited's current -78.46% should be judged against Healthcare norms (sector average: 9.71%) and against BITRF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -78.46%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.71%. From there, open related valuation or income-statement pages for Biotron Limited, and consider following BITRF for alerts when major investors trade the stock.